Dr. Schwartzberg has served on the board of directors for the National Comprehensive Cancer Network and participated actively as a guideline panel member for the NCCN breast, antiemesis, and myeloid growth factor panels for seven years. He also founded and served as the executive director of the ACORN research network. Dr. Schwartzberg’s research interests include new therapeutic approaches to breast cancer, targeted therapy, and supportive care. Dr. Schwartzberg has published over 300 peer reviewed manuscripts, book chapters and monographs.
Fellowship: Memorial Sloan-Kettering Cancer Center
New York Medical College Residency: North Shore Univ Hospital
